nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—Sulfasalazine—Vismodegib—skin cancer	0.422	0.732	CrCrCtD
Sulfadiazine—Sulfapyridine—Vismodegib—skin cancer	0.155	0.269	CrCrCtD
Sulfadiazine—CYP2C8—Vismodegib—skin cancer	0.0691	0.195	CbGbCtD
Sulfadiazine—CYP2E1—Dacarbazine—skin cancer	0.056	0.158	CbGbCtD
Sulfadiazine—CYP2C9—Vismodegib—skin cancer	0.0482	0.136	CbGbCtD
Sulfadiazine—CYP3A4—Temozolomide—skin cancer	0.0404	0.114	CbGbCtD
Sulfadiazine—CYP3A4—Imiquimod—skin cancer	0.0404	0.114	CbGbCtD
Sulfadiazine—CYP3A4—Vismodegib—skin cancer	0.028	0.0792	CbGbCtD
Sulfadiazine—CYP2C8—Fluorouracil—skin cancer	0.0245	0.0694	CbGbCtD
Sulfadiazine—CYP3A4—Vemurafenib—skin cancer	0.0221	0.0626	CbGbCtD
Sulfadiazine—CYP2C9—Fluorouracil—skin cancer	0.0171	0.0484	CbGbCtD
Sulfadiazine—CYP3A4—Docetaxel—skin cancer	0.0076	0.0215	CbGbCtD
Sulfadiazine—Muscle contracture—Dactinomycin—skin cancer	0.00434	0.0623	CcSEcCtD
Sulfadiazine—Periorbital oedema—Bleomycin—skin cancer	0.00182	0.0261	CcSEcCtD
Sulfadiazine—Reaction gastrointestinal—Docetaxel—skin cancer	0.00121	0.0174	CcSEcCtD
Sulfadiazine—Drug fever—Docetaxel—skin cancer	0.00121	0.0174	CcSEcCtD
Sulfadiazine—Eruption—Dactinomycin—skin cancer	0.00109	0.0157	CcSEcCtD
Sulfadiazine—Lupus erythematosus—Docetaxel—skin cancer	0.00108	0.0155	CcSEcCtD
Sulfadiazine—Skin exfoliation—Imiquimod—skin cancer	0.000968	0.0139	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00078	0.0112	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.000777	0.0111	CcSEcCtD
Sulfadiazine—Purpura—Imiquimod—skin cancer	0.000764	0.0109	CcSEcCtD
Sulfadiazine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00073	0.0105	CcSEcCtD
Sulfadiazine—Arthralgia—Vismodegib—skin cancer	0.000716	0.0103	CcSEcCtD
Sulfadiazine—Skin exfoliation—Bleomycin—skin cancer	0.000688	0.00986	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00066	0.00945	CcSEcCtD
Sulfadiazine—Eruption—Docetaxel—skin cancer	0.000657	0.00942	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Vemurafenib—skin cancer	0.000652	0.00934	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Dactinomycin—skin cancer	0.000631	0.00904	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000626	0.00897	CcSEcCtD
Sulfadiazine—Decreased appetite—Vismodegib—skin cancer	0.000597	0.00856	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vismodegib—skin cancer	0.000593	0.0085	CcSEcCtD
Sulfadiazine—Sepsis—Dactinomycin—skin cancer	0.000583	0.00836	CcSEcCtD
Sulfadiazine—Burning sensation—Docetaxel—skin cancer	0.000582	0.00834	CcSEcCtD
Sulfadiazine—Skin exfoliation—Temozolomide—skin cancer	0.00058	0.00832	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Temozolomide—skin cancer	0.000571	0.00818	CcSEcCtD
Sulfadiazine—Depression—Imiquimod—skin cancer	0.000566	0.00811	CcSEcCtD
Sulfadiazine—Erythema multiforme—Vemurafenib—skin cancer	0.000565	0.00809	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000562	0.00806	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vismodegib—skin cancer	0.000562	0.00805	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Imiquimod—skin cancer	0.000556	0.00797	CcSEcCtD
Sulfadiazine—Abdominal pain—Vismodegib—skin cancer	0.000543	0.00778	CcSEcCtD
Sulfadiazine—Neuritis—Docetaxel—skin cancer	0.000541	0.00776	CcSEcCtD
Sulfadiazine—Chills—Vemurafenib—skin cancer	0.000536	0.00768	CcSEcCtD
Sulfadiazine—Vascular purpura—Temozolomide—skin cancer	0.000493	0.00707	CcSEcCtD
Sulfadiazine—Sepsis—Fluorouracil—skin cancer	0.000486	0.00696	CcSEcCtD
Sulfadiazine—Pruritus—Vismodegib—skin cancer	0.000486	0.00696	CcSEcCtD
Sulfadiazine—Erythema multiforme—Imiquimod—skin cancer	0.000482	0.0069	CcSEcCtD
Sulfadiazine—Tinnitus—Imiquimod—skin cancer	0.000475	0.0068	CcSEcCtD
Sulfadiazine—Diarrhoea—Vismodegib—skin cancer	0.00047	0.00673	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Temozolomide—skin cancer	0.000468	0.0067	CcSEcCtD
Sulfadiazine—Purpura—Temozolomide—skin cancer	0.000458	0.00656	CcSEcCtD
Sulfadiazine—Chills—Imiquimod—skin cancer	0.000457	0.00655	CcSEcCtD
Sulfadiazine—Arthralgia—Vemurafenib—skin cancer	0.000443	0.00634	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000439	0.00629	CcSEcCtD
Sulfadiazine—Oliguria—Docetaxel—skin cancer	0.000439	0.00629	CcSEcCtD
Sulfadiazine—Vomiting—Vismodegib—skin cancer	0.000437	0.00626	CcSEcCtD
Sulfadiazine—Rash—Vismodegib—skin cancer	0.000433	0.00621	CcSEcCtD
Sulfadiazine—Dermatitis—Vismodegib—skin cancer	0.000433	0.0062	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vemurafenib—skin cancer	0.000424	0.00608	CcSEcCtD
Sulfadiazine—Ataxia—Temozolomide—skin cancer	0.000415	0.00594	CcSEcCtD
Sulfadiazine—Nausea—Vismodegib—skin cancer	0.000408	0.00585	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000397	0.00569	CcSEcCtD
Sulfadiazine—Stomatitis—Bleomycin—skin cancer	0.000393	0.00563	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000387	0.00554	CcSEcCtD
Sulfadiazine—Skin exfoliation—Docetaxel—skin cancer	0.000386	0.00553	CcSEcCtD
Sulfadiazine—Convulsion—Imiquimod—skin cancer	0.000384	0.0055	CcSEcCtD
Sulfadiazine—Ataxia—Fluorouracil—skin cancer	0.000382	0.00548	CcSEcCtD
Sulfadiazine—Arthralgia—Imiquimod—skin cancer	0.000377	0.00541	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000373	0.00534	CcSEcCtD
Sulfadiazine—Decreased appetite—Vemurafenib—skin cancer	0.000369	0.00529	CcSEcCtD
Sulfadiazine—Stomatitis—Dactinomycin—skin cancer	0.000366	0.00525	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000366	0.00525	CcSEcCtD
Sulfadiazine—Agranulocytosis—Dactinomycin—skin cancer	0.000351	0.00503	CcSEcCtD
Sulfadiazine—Sepsis—Docetaxel—skin cancer	0.000351	0.00503	CcSEcCtD
Sulfadiazine—Anorexia—Imiquimod—skin cancer	0.000345	0.00494	CcSEcCtD
Sulfadiazine—Depression—Temozolomide—skin cancer	0.000339	0.00486	CcSEcCtD
Sulfadiazine—Hepatitis—Dactinomycin—skin cancer	0.000337	0.00484	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000337	0.00483	CcSEcCtD
Sulfadiazine—Body temperature increased—Vemurafenib—skin cancer	0.000335	0.00481	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Temozolomide—skin cancer	0.000333	0.00478	CcSEcCtD
Sulfadiazine—Stomatitis—Temozolomide—skin cancer	0.000331	0.00475	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00033	0.00472	CcSEcCtD
Sulfadiazine—Insomnia—Imiquimod—skin cancer	0.000327	0.00469	CcSEcCtD
Sulfadiazine—Chills—Bleomycin—skin cancer	0.000325	0.00465	CcSEcCtD
Sulfadiazine—Erythema multiforme—Dactinomycin—skin cancer	0.000319	0.00457	CcSEcCtD
Sulfadiazine—Decreased appetite—Imiquimod—skin cancer	0.000315	0.00451	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vemurafenib—skin cancer	0.000313	0.00448	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000312	0.00448	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000307	0.0044	CcSEcCtD
Sulfadiazine—Stomatitis—Fluorouracil—skin cancer	0.000305	0.00438	CcSEcCtD
Sulfadiazine—Hepatitis—Temozolomide—skin cancer	0.000305	0.00437	CcSEcCtD
Sulfadiazine—Hallucination—Temozolomide—skin cancer	0.000304	0.00435	CcSEcCtD
Sulfadiazine—Chills—Dactinomycin—skin cancer	0.000303	0.00434	CcSEcCtD
Sulfadiazine—Pruritus—Vemurafenib—skin cancer	0.0003	0.0043	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Imiquimod—skin cancer	0.000296	0.00424	CcSEcCtD
Sulfadiazine—Agranulocytosis—Fluorouracil—skin cancer	0.000292	0.00419	CcSEcCtD
Sulfadiazine—Diarrhoea—Vemurafenib—skin cancer	0.00029	0.00416	CcSEcCtD
Sulfadiazine—Erythema multiforme—Temozolomide—skin cancer	0.000289	0.00414	CcSEcCtD
Sulfadiazine—Urticaria—Imiquimod—skin cancer	0.000287	0.00412	CcSEcCtD
Sulfadiazine—Abdominal pain—Imiquimod—skin cancer	0.000286	0.0041	CcSEcCtD
Sulfadiazine—Body temperature increased—Imiquimod—skin cancer	0.000286	0.0041	CcSEcCtD
Sulfadiazine—Tinnitus—Temozolomide—skin cancer	0.000285	0.00408	CcSEcCtD
Sulfadiazine—Leukopenia—Bleomycin—skin cancer	0.000282	0.00404	CcSEcCtD
Sulfadiazine—Ataxia—Docetaxel—skin cancer	0.000276	0.00395	CcSEcCtD
Sulfadiazine—Chills—Temozolomide—skin cancer	0.000274	0.00392	CcSEcCtD
Sulfadiazine—Vomiting—Vemurafenib—skin cancer	0.00027	0.00387	CcSEcCtD
Sulfadiazine—Rash—Vemurafenib—skin cancer	0.000268	0.00383	CcSEcCtD
Sulfadiazine—Dermatitis—Vemurafenib—skin cancer	0.000267	0.00383	CcSEcCtD
Sulfadiazine—Hypersensitivity—Imiquimod—skin cancer	0.000267	0.00382	CcSEcCtD
Sulfadiazine—Headache—Vemurafenib—skin cancer	0.000266	0.00381	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000264	0.00379	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—skin cancer	0.000263	0.00377	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Bleomycin—skin cancer	0.000257	0.00368	CcSEcCtD
Sulfadiazine—Pruritus—Imiquimod—skin cancer	0.000256	0.00367	CcSEcCtD
Sulfadiazine—Nausea—Vemurafenib—skin cancer	0.000252	0.00361	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Bleomycin—skin cancer	0.000252	0.00361	CcSEcCtD
Sulfadiazine—Diarrhoea—Imiquimod—skin cancer	0.000248	0.00355	CcSEcCtD
Sulfadiazine—Anorexia—Bleomycin—skin cancer	0.000245	0.00351	CcSEcCtD
Sulfadiazine—Vertigo—Temozolomide—skin cancer	0.000239	0.00342	CcSEcCtD
Sulfadiazine—Leukopenia—Temozolomide—skin cancer	0.000238	0.00341	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—skin cancer	0.000235	0.00336	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000234	0.00336	CcSEcCtD
Sulfadiazine—Convulsion—Temozolomide—skin cancer	0.00023	0.0033	CcSEcCtD
Sulfadiazine—Vomiting—Imiquimod—skin cancer	0.00023	0.0033	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—skin cancer	0.000229	0.00327	CcSEcCtD
Sulfadiazine—Rash—Imiquimod—skin cancer	0.000228	0.00327	CcSEcCtD
Sulfadiazine—Dermatitis—Imiquimod—skin cancer	0.000228	0.00327	CcSEcCtD
Sulfadiazine—Headache—Imiquimod—skin cancer	0.000227	0.00325	CcSEcCtD
Sulfadiazine—Arthralgia—Temozolomide—skin cancer	0.000226	0.00324	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000224	0.00321	CcSEcCtD
Sulfadiazine—Decreased appetite—Bleomycin—skin cancer	0.000223	0.0032	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Docetaxel—skin cancer	0.000222	0.00318	CcSEcCtD
Sulfadiazine—Stomatitis—Docetaxel—skin cancer	0.00022	0.00316	CcSEcCtD
Sulfadiazine—Leukopenia—Fluorouracil—skin cancer	0.000219	0.00314	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000218	0.00313	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Temozolomide—skin cancer	0.000217	0.00311	CcSEcCtD
Sulfadiazine—Nausea—Imiquimod—skin cancer	0.000215	0.00308	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Temozolomide—skin cancer	0.000212	0.00304	CcSEcCtD
Sulfadiazine—Convulsion—Fluorouracil—skin cancer	0.000212	0.00304	CcSEcCtD
Sulfadiazine—Agranulocytosis—Docetaxel—skin cancer	0.000211	0.00302	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—skin cancer	0.000208	0.00299	CcSEcCtD
Sulfadiazine—Anorexia—Temozolomide—skin cancer	0.000207	0.00296	CcSEcCtD
Sulfadiazine—Urticaria—Bleomycin—skin cancer	0.000204	0.00293	CcSEcCtD
Sulfadiazine—Body temperature increased—Bleomycin—skin cancer	0.000203	0.00291	CcSEcCtD
Sulfadiazine—Hepatitis—Docetaxel—skin cancer	0.000203	0.00291	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Fluorouracil—skin cancer	0.0002	0.00286	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000198	0.00283	CcSEcCtD
Sulfadiazine—Insomnia—Temozolomide—skin cancer	0.000196	0.00281	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000196	0.00281	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Fluorouracil—skin cancer	0.000196	0.0028	CcSEcCtD
Sulfadiazine—Erythema multiforme—Docetaxel—skin cancer	0.000192	0.00275	CcSEcCtD
Sulfadiazine—Anorexia—Fluorouracil—skin cancer	0.00019	0.00273	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—skin cancer	0.00019	0.00272	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—skin cancer	0.00019	0.00272	CcSEcCtD
Sulfadiazine—Hypersensitivity—Bleomycin—skin cancer	0.000189	0.00271	CcSEcCtD
Sulfadiazine—Decreased appetite—Temozolomide—skin cancer	0.000188	0.0027	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000187	0.00268	CcSEcCtD
Sulfadiazine—Chills—Docetaxel—skin cancer	0.000182	0.00261	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000182	0.00261	CcSEcCtD
Sulfadiazine—Pruritus—Bleomycin—skin cancer	0.000182	0.00261	CcSEcCtD
Sulfadiazine—Insomnia—Fluorouracil—skin cancer	0.000181	0.00259	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Temozolomide—skin cancer	0.000177	0.00254	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—skin cancer	0.000177	0.00253	CcSEcCtD
Sulfadiazine—Decreased appetite—Fluorouracil—skin cancer	0.000174	0.00249	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000172	0.00247	CcSEcCtD
Sulfadiazine—Urticaria—Temozolomide—skin cancer	0.000172	0.00247	CcSEcCtD
Sulfadiazine—Abdominal pain—Temozolomide—skin cancer	0.000171	0.00246	CcSEcCtD
Sulfadiazine—Body temperature increased—Temozolomide—skin cancer	0.000171	0.00246	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—skin cancer	0.000164	0.00235	CcSEcCtD
Sulfadiazine—Vomiting—Bleomycin—skin cancer	0.000163	0.00234	CcSEcCtD
Sulfadiazine—Rash—Bleomycin—skin cancer	0.000162	0.00232	CcSEcCtD
Sulfadiazine—Dermatitis—Bleomycin—skin cancer	0.000162	0.00232	CcSEcCtD
Sulfadiazine—Hypersensitivity—Temozolomide—skin cancer	0.00016	0.00229	CcSEcCtD
Sulfadiazine—Urticaria—Fluorouracil—skin cancer	0.000159	0.00227	CcSEcCtD
Sulfadiazine—Leukopenia—Docetaxel—skin cancer	0.000158	0.00227	CcSEcCtD
Sulfadiazine—Body temperature increased—Fluorouracil—skin cancer	0.000158	0.00226	CcSEcCtD
Sulfadiazine—Pruritus—Temozolomide—skin cancer	0.000153	0.0022	CcSEcCtD
Sulfadiazine—Convulsion—Docetaxel—skin cancer	0.000153	0.00219	CcSEcCtD
Sulfadiazine—Nausea—Bleomycin—skin cancer	0.000153	0.00219	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—skin cancer	0.000152	0.00218	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—skin cancer	0.000151	0.00217	CcSEcCtD
Sulfadiazine—Arthralgia—Docetaxel—skin cancer	0.00015	0.00216	CcSEcCtD
Sulfadiazine—Diarrhoea—Temozolomide—skin cancer	0.000148	0.00213	CcSEcCtD
Sulfadiazine—Hypersensitivity—Fluorouracil—skin cancer	0.000147	0.00211	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Docetaxel—skin cancer	0.000144	0.00207	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—skin cancer	0.000142	0.00204	CcSEcCtD
Sulfadiazine—Pruritus—Fluorouracil—skin cancer	0.000141	0.00203	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Docetaxel—skin cancer	0.000141	0.00202	CcSEcCtD
Sulfadiazine—Vomiting—Temozolomide—skin cancer	0.000138	0.00198	CcSEcCtD
Sulfadiazine—Anorexia—Docetaxel—skin cancer	0.000137	0.00197	CcSEcCtD
Sulfadiazine—Rash—Temozolomide—skin cancer	0.000137	0.00196	CcSEcCtD
Sulfadiazine—Diarrhoea—Fluorouracil—skin cancer	0.000137	0.00196	CcSEcCtD
Sulfadiazine—Dermatitis—Temozolomide—skin cancer	0.000137	0.00196	CcSEcCtD
Sulfadiazine—Headache—Temozolomide—skin cancer	0.000136	0.00195	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000131	0.00188	CcSEcCtD
Sulfadiazine—Insomnia—Docetaxel—skin cancer	0.00013	0.00187	CcSEcCtD
Sulfadiazine—Nausea—Temozolomide—skin cancer	0.000129	0.00185	CcSEcCtD
Sulfadiazine—Vomiting—Fluorouracil—skin cancer	0.000127	0.00182	CcSEcCtD
Sulfadiazine—Rash—Fluorouracil—skin cancer	0.000126	0.00181	CcSEcCtD
Sulfadiazine—Dermatitis—Fluorouracil—skin cancer	0.000126	0.0018	CcSEcCtD
Sulfadiazine—Decreased appetite—Docetaxel—skin cancer	0.000125	0.0018	CcSEcCtD
Sulfadiazine—Headache—Fluorouracil—skin cancer	0.000125	0.00179	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000124	0.00178	CcSEcCtD
Sulfadiazine—Nausea—Fluorouracil—skin cancer	0.000119	0.0017	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Docetaxel—skin cancer	0.000118	0.00169	CcSEcCtD
Sulfadiazine—Abdominal pain—Docetaxel—skin cancer	0.000114	0.00163	CcSEcCtD
Sulfadiazine—Body temperature increased—Docetaxel—skin cancer	0.000114	0.00163	CcSEcCtD
Sulfadiazine—Hypersensitivity—Docetaxel—skin cancer	0.000106	0.00152	CcSEcCtD
Sulfadiazine—Pruritus—Docetaxel—skin cancer	0.000102	0.00146	CcSEcCtD
Sulfadiazine—Diarrhoea—Docetaxel—skin cancer	9.87e-05	0.00141	CcSEcCtD
Sulfadiazine—Vomiting—Docetaxel—skin cancer	9.17e-05	0.00131	CcSEcCtD
Sulfadiazine—Rash—Docetaxel—skin cancer	9.09e-05	0.0013	CcSEcCtD
Sulfadiazine—Dermatitis—Docetaxel—skin cancer	9.08e-05	0.0013	CcSEcCtD
Sulfadiazine—Headache—Docetaxel—skin cancer	9.03e-05	0.00129	CcSEcCtD
Sulfadiazine—Nausea—Docetaxel—skin cancer	8.56e-05	0.00123	CcSEcCtD
